Silo Pharma, Inc. (SILO) Total Assets by Year
Silo Pharma, Inc. closed fiscal year 2025 with $7.6M in total assets, $1.3M in total liabilities and $6.3M in shareholder equity. This represents an increase of 2.6% from the prior fiscal year. The table below carries 12 fiscal years, from 2011 to 2025, and the quarters Silo Pharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SILO Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25POS AM | FY24POS AM | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.6M+2.6% | $7.4M-4.3% | $7.7M-33.5% | $11.6M+11.0% | $10.5M+635.3% | $1.4M+188.9% | $494K-42.3% | $855K-47.9% | $1.6M | $2.2M+791077.1% | $279-84.1% | $2K |
| Total Liabilities | $1.3M-45.3% | $2.4M+51.5% | $1.6M+20.5% | $1.3M-8.8% | $1.4M+878.2% | $146K-71.8% | $517K+15.3% | $448K+2.2% | $438K | $19K-54.9% | $41K+1084.9% | $4K |
| Total Equity | $6.3M+25.3% | $5.0M-18.5% | $6.2M-40.3% | $10.3M+14.1% | $9.1M+607.6% | $1.3M+5694.5% | -$23K-105.6% | $407K-66.1% | $1.2M | $1.8M+4442.1% | -$41K-2256.6% | -$2K |
SILO Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'24POS AM | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.0M-10.5% | $7.0M+19.0% | $7.6M+2.6% | $6.4M-25.5% | $6.7M-17.2% | $5.9M-15.0% | $7.4M-4.3% | $8.6M-4.7% | $8.0M-21.5% | $6.9M-37.0% | $7.7M-33.5% | $9.0M-31.1% |
| Total Liabilities | $1.1M-38.6% | $1.3M-29.3% | $1.3M-45.3% | $1.4M-22.9% | $1.7M-16.6% | $1.9M+14.5% | $2.4M+51.5% | $1.8M+19.7% | $2.1M+6.7% | $1.6M+4.4% | $1.6M+20.5% | $1.5M+24.6% |
| Total Equity | $4.9M-0.6% | $5.7M+41.7% | $6.3M+25.3% | $5.0M-26.1% | $4.9M-17.5% | $4.0M-24.2% | $5.0M-18.5% | $6.8M-9.5% | $6.0M-28.2% | $5.3M-44.0% | $6.2M-40.3% | $7.5M-36.8% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Silo Pharma, Inc. financials
Frequently Asked Questions
What was Silo Pharma, Inc.'s total assets in fiscal year 2025?
Silo Pharma, Inc. closed fiscal year 2025 with $7.6M in total assets, $1.3M in total liabilities and $6.3M in shareholder equity.
How fast is Silo Pharma, Inc.'s total assets growing?
Silo Pharma, Inc. (SILO) total assets rose by 2.6% year over year, from $7.4M to $7.6M in fiscal year 2025.
How has Silo Pharma, Inc.'s total assets changed over the years?
Across the 12 fiscal years this page covers, Silo Pharma, Inc. (SILO) total assets went from $2K in fiscal year 2011 to $7.6M in fiscal year 2025.
What was Silo Pharma, Inc.'s total assets in the most recent quarter?
Silo Pharma, Inc. (SILO) reported $6.0M in total assets in Q2 2026. This represents a decrease of 10.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Silo Pharma, Inc. (SILO) reported on that line in every period on record.